eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 07/07/2009
PIL Rilutek 50 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/08/2008 and displayed until 07/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 13/06/2007 and displayed until 01/08/2008
Reasons for adding or updating:
  • Addition of Marketing Authorisation Holder
Updated on 10/05/2006 and displayed until 13/06/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 18/03/2003 and displayed until 10/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 11/12/2001 and displayed until 18/03/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 11/12/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 29/11/2000 and displayed until 22/03/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 09/08/2000 and displayed until 29/11/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   riluzole